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Abstract
The ROP16 kinase of Toxoplasma gondii is injected into the host cell cytosol where it activates signal transducer and
activator of transcription (STAT)-3 and STAT6. Here, we generated a ROP16 deletion mutant on a Type I parasite strain
background, as well as a control complementation mutant with restored ROP16 expression. We investigated the biological
role of the ROP16 molecule during T. gondii infection. Infection of mouse bone marrow-derived macrophages with rop16-
deleted (DROP16) parasites resulted in increased amounts of IL-12p40 production relative to the ROP16-positive RH parental
strain. High level IL-12p40 production in DROP16 infection was dependent on the host cell adaptor molecule MyD88, but
surprisingly was independent of any previously recognized T. gondii triggered pathway linking to MyD88 (TLR2, TLR4, TLR9,
TLR11, IL-1ß and IL-18). In addition, ROP16 was found to mediate the suppressive effects of Toxoplasma on LPS-induced
cytokine synthesis in macrophages and on IFN-c-induced nitric oxide production by astrocytes and microglial cells.
Furthermore, ROP16 triggered synthesis of host cell arginase-1 in a STAT6-dependent manner. In fibroblasts and
macrophages, failure to induce arginase-1 by DROP16 tachyzoites resulted in resistance to starvation conditions of limiting
arginine, an essential amino acid for replication and virulence of this parasite. DROP16 tachyzoites that failed to induce host
cell arginase-1 displayed increased replication and dissemination during in vivo infection. We conclude that encounter
between Toxoplasma ROP16 and the host cell STAT signaling cascade has pleiotropic downstream effects that act in
multiple and complex ways to direct the course of infection.
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Introduction
Pathogens living in an intracellular compartment benefit from
being able to parasitize their host cell for nutrients, but they are
faced with the challenge of surviving within a potentially hostile
environment. This is particularly the case for microorganisms that
infect cells of innate immunity such as macrophage/monocytes
and dendritic cells because these cells possess potent microbial
sensing and killing machinery. Many of the mechanisms that viral
and bacterial pathogens use to manipulate host cell signaling
pathways are well characterized, but less is known about how
intracellular eukaryotic pathogens mechanistically interact with
host cell signal transduction [1,2,3].
For one intracellular protozoan, Toxoplasma gondii, this is
changing. Toxoplasma is an extremely successful microorganism
as evidenced by the fact that it infects up to 50% of the human
population worldwide and is also a common parasite in domestic
and wild animals [4]. Within the host there is evidence that
Toxoplasma preferentially targets dendritic cells, monocyte/macro-
phage lineage cells and neutrophils [5,6,7]. Infection is normally
asymptomatic, and is characterized by widespread dissemination
of replicative tachyzoites followed by formation of quiescent cysts
in the central nervous system and skeletal muscle tissues that
persist for the lifetime of the host with no overt ill effects. Yet, T.
gondii is an important opportunistic pathogen insofar as infection in
immunocompromised patients may have life-threatening conse-
quences, and in utero infection can lead to major defects in the
fetus [8,9]. The parasite is normally controlled by a strong Type 1
cytokine response characterized by high-level production of
cytokines such as IL-12p70, TNF-a and IFN-c [10]. While the
latter cytokines are important in resistance to infection, this
proinflammatory response must be tightly controlled to avoid
immunopathology that can otherwise lead to host death.
It is well established that Toxoplasma actively interferes with host
cell signaling during intracellular infection of cells such as
macrophages (MØ) [11]. The parasite is capable of blocking
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tory responses initiated by signaling through the IFN-c receptor
and Toll-like receptors (TLR). How these suppressive effects occur
is less well known, although induction of suppressor of cytokine
synthesis (SOCS)-1, activation of phosphatidylinositol (PI)-3 kinase
signaling, inhibition of NFkB activation, and blocking chromatin
remodeling have each been implicated in parasite-mediated
interference with host cell signaling [12,13,14,15,16].
Recently, the signal transducer and activator of transcription
(STAT) signaling pathway has emerged as a major target of
exploitation by T. gondii. Infection of mouse bone marrow-derived
MØ induces rapid and sustained activation of STAT3, a
transcription factor through which the anti-inflammatory cytokine
IL-10 exerts its function [17]. Additionally, STAT3-negative MØ
are much less sensitive to parasite-mediated inhibition of TLR
signaling.
Parasite strain type is a critical determinant of STAT3
activation. Of the three predominant strain types, high virulence
Type I and low virulence Type III parasites are potent activators
of STAT3, whereas low virulence Type II strains are incapable of
sustained activation. A major advance in our understanding of
how Toxoplasma interacts with the STAT signaling machinery
came from the results of genetic crosses between T. gondii strain
types. In these studies the rop16 locus, contained on chromosome
VIIb, emerged as a determinant of activation of both STAT3 and
STAT6 [18,19].
The rop16 locus encodes rhoptry protein ROP16. This
molecule, along with several other proteins, is contained within
rhoptries, which are apically associated organelles that discharge
their contents during invasion. While many rhoptry proteins
localize to the parasitophorous vacuole membrane, some are
injected into the host cell cytoplasm associated with empty
(e)-vacuoles [20]. The ROP16 molecule is discharged into the
cytosol during invasion, and it rapidly translocates to the host cell
nucleus via a nuclear translocation sequence [19]. Although
originally identified as a putative serine-threonine kinase, recent
biochemical studies have shown that ROP16 from Type I
parasites is capable of directly catalyzing tyrosine phosphorylation
of both STAT3 and STAT6 [21,22].
Here, we used reverse genetics to generate ROP16 negative
(DROP16) Type 1 parasites as well as ROP16 complementation
mutants (DROP16:1), and we studied the biological effects of
deleting and re-inserting this gene during in vitro and in vivo
infection. We report that ROP16 deletion converts Type I
tachyzoites from low to high inducers of IL-12p40, and
simultaneously abrogates the suppressive effect of Toxoplasma on
TLR signaling. We show that ROP16 deletion eliminates the
parasite’s ability to block nitric oxide production mediated by
signaling through the IFN-c receptor. Yet, paradoxically,
DROP16 tachyzoites displayed increased replication during in
vivo and in vitro infection. We traced this activity to ROP16-
dependent STAT6-mediated induction of arginase-1, an enzyme
that degrades host cell arginine, which is required for both the
production of nitric oxide by host cell inducible nitric oxide
synthase, as well as being an essential amino acid nutrient the
parasite requires for intracellular replication.
Results
An inhibitor of JAK2 blocks parasite-induced STAT3
phosphorylation
Signal transduction resulting in STAT3 tyrosine phosphoryla-
tion involves upstream Janus kinase (JAK) activation triggered by
cytokine receptor engagement. To determine whether Toxoplasma
infection stimulates JAK1 or JAK2 phosphorylation, MØ were
infected with RH strain tachyzoites, and cell lysates were subjected
to immunoprecipitation with anti-phosphotyrosine antibody
followed by Western blotting with antibodies specific for JAK1,
JAK2 and STAT3 molecules. As shown in Fig. S1A, infection
triggered tyrosine phosphorylation of both JAK1 and JAK2, in
addition to STAT3.
The embryonic lethality of deleting JAK1 and JAK2 precluded
us from examining the role of these molecules in parasite-triggered
STAT3 activation, although experiments with Jak3
2/2 and
Tyk2
2/2 MØ revealed that these kinases were not involved (Fig.
S1B). However, we found that JAK inhibitor I, a relatively
nonspecific reagent, partially blocked parasite-mediated STAT3
activation (Fig. S1C). Furthermore, Toxoplasma-induced STAT3
phosphorylation was almost completely blocked by a JAK2-
specific inhibitor (Fig. S1D). In contrast, STAT3 phosphorylation
stimulated by recombinant IL-6 was largely unaffected by the
JAK2 inhibitor. This result is consistent with data suggesting that
IL-6-mediated STAT3 activation involves JAK1 and JAK3
molecules [23]. While the most straightforward conclusion of
these results is that parasite-triggered JAK2 activation mediates
STAT3 phosphorylation, this interpretation must be treated with
caution in light of recent evidence that ROP16 directly acts on
STAT molecules in a manner sensitive to JAK chemical inhibition
[21].
Generation of ROP16 deletion parasite (DROP16) and
ROP16 complemented strain (DROP16:1)
To examine the biological role of ROP16 regarding STAT
activation and modification of host responses, we generated Type
1 parasites lacking expression of this molecule. The ROP16 coding
region was targeted and deleted in the Type I RH strain KU80
knockout background [24] (Fig. S2A). PCR assays performed on
MPA-resistant clones validated efficient isolation of ROP16
knockouts (DROP16) as assessed by deletion of the ROP16
coding region (Fig. S2B), as well as by the correct targeted
integration of the HXGPRT marker into the deleted ROP16 locus
Author Summary
Toxoplasma gondii is an extremely widespread intracellular
protozoan parasite that establishes long-lasting infection
in humans and animals. Because Toxoplasma infection is
most often asymptomatic, it is evident that this parasite
has developed sophisticated ways to manipulate host
immunity. Recently, the parasite ROP16 kinase was
identified as an important determinant of host cell
signaling. During cell invasion, ROP16 is injected into the
host cell cytoplasm and subsequently localizes to the
nucleus. Here, we report the generation of ROP16
knockout parasites (DROP16) as well as DROP16 comple-
mentation mutants (DROP16:1) and we describe the
biological effects of deleting and re-inserting this mole-
cule. We find that ROP16 controls the ability to activate
multiple host cell signaling pathways and simultaneously
suppress macrophage proinflammatory responses. Dele-
tion of ROP16 increases parasite ability to replicate and
disseminate during in vivo infection. This increased growth
response may arise from ROP16-dependent activation of
host arginase-1. Induction of arginase-1 limits availability
of arginine, an amino acid that is required for parasite
growth and host-inducible nitric oxide production. Our
results provide new insight into the complex interactions
between an intracellular eukaryotic pathogen and its host
cell.
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was then complemented with a single copy of a functional allele of
ROP16 from type I RH by replacement of HXGPRT at the
ROP16-deleted locus to generate strain DROP16:1 (Fig. S2E).
The DROP16:1 complemented strain exhibited the expected
genotype at the ROP16 locus (Fig. S2F, G, H).
ROP16 deletion attenuates STAT3 tyrosine
phosphorylation
We examined phosphorylation kinetics in MØ infected with
either wild-type or ROP16 knockout (DROP16) or complemented
(DROP16:1) parasites (Fig. 1A). As expected, wild-type RH strain
tachyzoites induced rapid and sustained STAT3 tyr
705 (pY-)
phosphorylation. In contrast, MØ infected with DROP16
parasites displayed early STAT3 tyrosine phosphorylation, but
this response was not sustained and phosphorylation levels
dropped to background within 1.5 h of infection. Re-introduction
of the rop16 gene into DROP16 knockout parasites restored
sustained STAT3 activation in the DROP16:1 strain (Fig. 1A).
Because initial STAT3 phosphorylation is clearly independent of
ROP16, but prolonged STAT3 activation requires ROP16, we
conclude that activation is a biphasic process mediated initially by
a host or parasite kinase independently of ROP16. Yamamoto
et al. (22) did not previously report transient ROP16-independent
activation of STAT3, most likely because samples were not
analyzed prior to 3 hr post-infection. Phosphorylation at the
ser
727 residue is required for full activation of STAT3 [25].
Although this response was more difficult to detect, we found that
parasite-mediated ser
727 STAT3 phosphorylation did not require
ROP16 expression (Fig. S3).
Because ROP16 deletion did not completely abrogate STAT3
tyrosine phosphorylation, we examined whether the active
transcription factor translocated to the nucleus during infection
with ROP16 knockout parasites. Nuclear extracts were prepared
from infected MØ and probed for total or pY-STAT3. As
demonstrated in Fig. 1B, cells infected with wild-type parasites
displayed rapid nuclear accumulation of pY-STAT3. In the
absence of ROP16, we also detected rapid accumulation of
phosphorylated STAT3 that was greatly reduced by 1.5 hr post-
infection even though total STAT3 levels remain elevated. In the
complemented DROP16:1 strain, levels of phosphorylated STAT3
were maintained in a manner similar to infection with parental
parasites. These data are consistent with those of others showing
continuous STAT3 shuttling from cytoplasm to nucleus indepen-
dent of phosphorylation status [26].
ROP16 down-modulates IL-12p40 production in infected
cells
We, and others, have shown that Type II Toxoplasma strains,
including PTG and ME49, induce higher levels of the IL-12p40
compared to infection with Type I strains such as RH [27,28].
Genetic segregation analysis of crosses between parasite strains
identified the rop16 locus as a determinant of IL-12 induction [19].
Therefore, we tested whether deletion of ROP16 would convert
the parasite into a strong IL-12 inducer, as would be predicted
from the forward genetics studies. As shown in Fig. 2, at 24 hr
Figure 1. Defective STAT3 tyrosine phosphorylation and nuclear accumulation in the absence of ROP16. (A) Cells were infected with
either RH, DROP16 or DROP16:1 tachyzoites (3:1 ratio parasites to cells), then total lysates were collected at the indicated times (hr) post-infection and
subjected to Western blotting. Blots were probed with anti-phospho-Tyr (Y)
705 STAT3 then stripped and re-probed with antibody to total STAT3. The
experiment was repeated 3 times with similar results. (B) Cells were infected as in (A), but at the indicated times nuclear preparations were prepared
and subjected to Western blot analysis for phospho-Tyr
705 STAT3 and, following membrane stripping, total STAT3. Immunoblotting for PARP and
Rab5a, nuclear and cytoplasmic proteins, respectively was also carried out. Cy, control cytoplasmic preparation. This experiment was repeated twice
with the same result.
doi:10.1371/journal.ppat.1002236.g001
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levels of IL-12. In contrast, deletion of ROP16 converted the
parasite into a strong IL-12 inducer. Confirming a role for the
rop16 gene in this response, complemented DROP16:1 parasites
induced low levels of IL-12 similar to wild-type tachyzoites.
Because the common adaptor of Toll-like receptor (TLR)
signaling, MyD88, has been implicated in immunity to T. gondii
and in particular in IL-12 MØ responses during Type II infection
[29,30,31], we examined whether DROP16-mediated IL-12p40
production was dependent upon this molecule. As shown in Fig. 3,
the ability of DROP16 tachyzoites to induce high-level IL-12
production was strongly dependent on MyD88. Previous reports
have provided evidence that TLR2 and TLR4 are involved in
innate recognition of tachyzoites, suggesting that these receptors
might mediate MyD88-dependent IL-12 production that occurs in
the absence of ROP16 [32,33]. However, DROP16 parasites
induced equivalent levels of IL-12p40 in both wild-type and
TLR2/4 double-knockout MØ (Fig. 3). Similarly, TLR9 and
TLR11 have been implicated in innate immune recognition of
Toxoplasma [34,35], but lack of these molecules had no effect on
high-level IL-12 production induced by parasites lacking ROP16
(Fig. 3). Finally, both IL-1b and IL-18 signaling involves MyD88
and it was therefore possible that autocrine production of these
cytokines resulted in DROP16-mediated IL-12 release. However,
MØ lacking caspase-1 (which is required for production of
bioactive forms of these cytokines) also produced high amounts of
IL-12p40 after infection with DROP16 parasites (Fig. 3). In these
experiments, littermates served as WT controls and cells were
obtained from mice at different facilities, likely contributing to
differences on overall cytokine production from strain to strain.
Nevertheless, we can conclude that parasite-induced IL-12 occurs
independently of these TLR, or alternatively that in the absence of
any single TLR, others can functionally substitute.
The MyD88 dependent IL-12 production we observed in the
absence of ROP16 recalls previous observations of MyD88
dependent high-level IL-12 production in Type II parasite
strain-infected cells [27]. One possibility that would explain the
effects of ROP16 on down-regulating IL-12 production is that this
rhoptry kinase might control IL-10 production. However, IL-10
was not detected in MyD88
2/2 MØ culture supernatants infected
with DROP16 tachyzoites (data not shown). In addition, we
previously demonstrated that IL-10 does not play a role in the
inhibition of IL-12 production by WT RH parasites [17].
Deletion of ROP16 abrogates the ability of Toxoplasma to
actively inhibit proinflammatory responses
Previously, we found that infection with Type I RH tachyzoites
inhibited MØ responses to LPS and other TLR ligands, and we
linked this inhibition phenotype to STAT3 activation [17].
Therefore, we examined whether ROP16 null parasites were
defective in their ability to inhibit LPS-induced cytokines. In these
experiments, MØ were infected followed 2 hr later by addition of
LPS. Six hr after LPS stimulation (at a time prior to induction of
IL-12 by parasites themselves) supernatants were collected for
ELISA. MØ cultured in medium alone followed by LPS
stimulation produced robust amounts of IL-12p40 and TNF-a
(Fig. 4A and B, respectively). While cells infected with wild-type
RH tachyzoites displayed a defective ability to respond to TLR
signaling, ROP16-deleted parasites lost their ability to suppress
LPS-induced cytokine production. However, re-introduction of
the rop16 gene restored the parasites’ ability to strongly suppress
LPS-induced IL-12p40 and TNF-a production (Fig. 4A and B).
Similar inhibitory effects of the RH strain on TLR-dependent
stimulation occur during infection of DC [5,36]. In contrast,
ROP16 negative parasites failed to display this strong inhibitory
effect during infection of DC (data not shown).
In addition to inhibition of signaling mediated through TLR
pathways, Toxoplasma is capable of down-regulating IFN-c-
triggered signaling that leads to iNOS-dependent nitric oxide
(NO) production [37]. Stimulation with IFN-c alone failed to elicit
significant amounts of NO in bone marrow-derived MØ,
thioglycollate elicited MØ, or bone marrow-derived DC (data
not shown). In addition, none of the parasite strains by themselves
triggered iNOS or NO production. However, both microglial cells
and astrocytes from noninfected neonatal mice produced NO after
IFN-c stimulation. When microglial cells were infected with RH
tachyzoites and subjected to cytokine stimulation, NO production
was severely limited (Fig. 5A). In marked contrast, infection with
ROP16 null parasites failed to result in NO inhibition. IFN-c
stimulation of astrocytes resulted in lower amounts of NO, and this
Figure 2. ROP16 negatively regulates IL-12p40 production.
Bone marrow-derived MØ were infected at a 3:1 ratio of parasites to
cells, then supernatants were collected after 24 hr and analyzed by
ELISA. This experiment was repeated 3 times with similar results.
doi:10.1371/journal.ppat.1002236.g002
Figure 3. Induction of IL-12 by DROP16 tachyzoites requires MyD88, but occurs independently of TLR2, TLR4, TLR9, TLR11, and
caspase-1. Bone marrow-derived MØ from wild-type, Myd88
2/2, TLR2/4
2/2, TLR9
2/2, TLR11
2/2 and caspase-1
2/2 mice were infected with DROP16
tachyzoites (3: 1 ratio of parasites to cells), and supernatants were collected for ELISA 24 hr later. These experiments were repeated twice with similar
results.
doi:10.1371/journal.ppat.1002236.g003
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when these cells were infected with DROP16 tachyzoites, IFN-c-
dependent NO production was even greater than that detected
after stimulation with IFN-c alone. Indeed, at priming concen-
trations of 4 nM and lower, IFN-c failed to elicit detectable NO
unless cells were infected with DROP16 parasites (Fig. 5B). Taken
together, we conclude that ROP16 is a major molecule mediating
inhibition of downstream targets of both TLR and IFN-c receptor
signaling pathways.
Because DROP16 parasites did not block and even potentiated
NO production by astrocytes, and because NO is important in
controlling the parasite in the brain, we examined tachyzoite
survival in astrocyte-enriched cell cultures. Cells were subjected to
priming with IFN-c for 3 hr and then infected with RH or
DROP16 parasites for 48 hr. Both parasite strains infected cells
equally well and replicated in the absence of IFN-c (data not
shown). However, as shown in Fig. 5C, while RH survived and
replicated within IFN-c primed astrocytes, DROP16 parasites
were significantly more susceptible to killing. DROP16 parasites
displayed weak labeling with Ab to tachyzoite-specific surface
antigen (SAG)-1 (p30) and the parasite form was compromised
(arrows in right panel of Fig. 5C). The percent infection (Fig. 5D)
and the number of tachyzoites per cell (Fig. 5E) were significantly
less in DROP16-infected astrocytes compared to RH-infected
cells.
ROP16 mediates STAT6-dependent arginase-1 induction
In addition to STAT3 activation, genetic linkage studies
implicated the rop16 locus in activation of STAT6. A major
downstream target of STAT6 signaling is arginase-1. This
Figure 4. ROP16 controls the ability of Toxoplasma to inhibit
LPS-induced cytokine production. Bone marrow-derived MØ were
infected with RH, DROP16 and DROP16:1 at a 3:1 ratio of tachyzoites to
cells. After 2 hr, cells were stimulated with LPS (100 ng/ml). Superna-
tants were collected 6 hr after LPS treatment and analyzed by ELISA for
IL-12p40 (A) or TNF-a (B). In these experiments, cytokine levels in
supernatants of cells cultured in medium alone or with parasites alone
was below the level of detection (50 pg/ml). These experiments were
repeated 3 times with similar result.
doi:10.1371/journal.ppat.1002236.g004
Figure 5. DROP16 tachyzoites do not inhibit IFN-c primed NO production in microglial cells and DROP16 parasites potentiate
production in astrocytes. Neonatal microglial cells (A) or astrocytes (B) were preincubated with the indicated amounts of IFN-c for 3 hr and either
left uninfected (grey bars) or infected with RH (black bars) or DROP16 (white bars) parasites (3:1 ratio of tachyzoites to cells). After 48 hr, supernatants
were analyzed for nitrite/nitrate as production as a measure of NO. (C) RH tachyzoites survive and replicate in IFN-c activated astrocytes, but DROP16
parasites are killed. Cultures were primed for 3 hr with IFN-c, infected with parasites (at a ratio of 1:1) and cultured an additional 48 hr before
immunofluorescence assay. Arrowheads point to degraded DROP16 parasites that stain irregularly with Ab specific for tachyzoite surface antigen
(SAG)-1. Green, parasites; red, phalloidin-stained actin; blue, nucleus. Both percentage of infected cells (D) and number of parasites per infected cell
(E) are significantly higher in RH- versus DROP16-infected cultures. Micrographs were scored for percent infection and intracellular parasite count. At
least 10 fields and 100 cells were counted for each infection. These collective experiments were repeated twice with the same result.
doi:10.1371/journal.ppat.1002236.g005
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iNOS for the amino acid substrate arginine [38,39,40]. Therefore,
we examined whether ROP16 could stimulate STAT6-dependent
arginase-1 production. As shown in Fig. 6A, RH induced strong
and sustained tyr
641 phosphorylation of STAT6. In marked
contrast, this response was completely absent in DROP16 mutant
tachyzoites. However, in the rop16 complemented strain, STAT6
activation was restored (Fig. 6A). The absolute dependence of
STAT6 phosphorylation on ROP16 differed from STAT3
activation, where only early ROP16-independent phosphorylation
occurred (Fig. 1A and Fig. S4, which shows nuclear lysates from a
single experiment blotted and probed for STAT3, then re-probed
for STAT6). Interestingly, we detected nuclear accumulation of
total STAT6, despite lack of detectable STAT6 tyrosine
phosphorylation during DROP16 infection (Fig. S4). This may
indicate phosphorylation-independent STAT nuclear accumula-
tion as reported by others [41].
Paralleling the STAT6 phosphorylation results, wild-type and
complemented parasites, but not DROP16 tachyzoites, induced
arginase-1 synthesis, a response detectable by immunoblotting for
arginase-1 protein within 6 hr of infection (Fig. 6A). Similarly, we
detected induction of arginase-1 by immunofluorescence assay
during RH but not DROP16 infection (Fig. 6B and C,
respectively). Because the arginase-1 gene is controlled by STAT6
signaling, we examined whether parasite-induced induction of
arginase-1 also depended upon STAT6. As shown in Fig. 6D,
infection of STAT6
2/2 MØ with all three strains failed to induce
arginase-1 protein, in contrast to infection of MØ from
STAT6
+/+ littermates in which we detected ROP16-dependent
arginase-1 induction. We did not detect production of IL-4/IL-13
in these cultures making it very unlikely that arginase-1 induction
was due to ROP16-dependent production of these cytokines
(data not shown).
ROP16 modulates the availability of the essential amino
acid arginine
Toxoplasma is known to be an arginine auxotroph, strictly
relying on either host or exogenously supplied arginine for its
replication and survival [42]. ROP16-dependent induction of
arginase-1 suggested that parasites lacking this rhoptry molecule
might be more resistant to conditions of arginine limitation.
Therefore, we compared the ability of wild type and DROP16
parasites to invade and multiply within fibroblasts cultured in
arginine-replete and arginine-deficient media. In normal arginine-
replete medium, RH (Fig. 7A) and DROP16 (Fig. 7B) parasites
displayed vigorous multiplication rates (quantitated in Fig. 7E).
However, under arginine limiting conditions, RH replication was
severely curtailed and only one cycle of replication occurred
during the 38 hr growth assay (Fig. 7C and E). In striking contrast,
replication of DROP16 parasites was markedly less affected by
arginine starvation, with evidence of 4 or more cycles of division
(Fig. 7D and E).
Although Toxoplasma is known as a microorganism that can
infect virtually any kind of nucleated cell, the parasite is often
found preferentially in macrophage/DC lineage cells during in
vivo infection [7]. Therefore, we also examined the growth
behavior of RH, DROP16 and DROP16:1 parasites under
arginine high and low conditions in bone marrow-derived MØ.
As shown in Fig. 7F, while all three strains replicated equivalently
under arginine replete conditions, deletion of ROP16 resulted in a
growth advantage to the parasites when arginine was present in
limiting concentration.
Along similar lines, we collected mouse resident peritoneal cells,
which are composed largely of CD11b
+ resting MØ and carried
out ex vivo infection with RH, DROP16 and DROP16:1 parasites
under arginine high and low conditions. As in mouse bone
marrow-derived MØ and human fibroblasts, in arginine limiting
Figure 6. ROP16 controls STAT6-dependent arginase-1 synthesis. (A) Bone marrow-derived MØ were infected with RH, DROP16 and
DROP16:1 tachyzoites (3: 1 ratio of parasites to cells), then at the indicated times (hr) post-infection total cell lysates were subjected to Western
blotting with phospho-STAT6 antibody. Blots were successively stripped and re-probed with antibodies to total STAT6, arginase-1 (Arg-1) and
GAPDH. (B and C) Bone marrow-derived MØ were infected with RH (B) or DROP16 (C), then 24 hr later cells were fixed and subjected to
immunofluorescence staining for arginase-1 expression. Red, arginase-1; green, Toxoplasma; blue, nucleus. (D) Stat6
2/2 and Stat6
+/+ bone marrow-
derived MØ were infected with the indicated parasite strains, then lysed and subjected to Western blot analysis with anti-Arg-1 antibody. Blots were
subsequently stripped and re-probed with a GAPDH-specific antibody. These experiments were performed 3 times with the same result.
doi:10.1371/journal.ppat.1002236.g006
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advantage on parasites as measured by overall average numbers of
tachyzoites per cell (Fig. 8A). While the distribution of parasite
number per cell was similar for all strains under arginine high
conditions (Fig. 8B), the presence of ROP16 in RH or the
complemented DROP16:1 strain reduced the number of parasites
per cell under arginine limiting conditions (Fig. 8C). In contrast,
the ROP16-deleted strain exhibited significantly higher numbers
of parasites per cell (Fig. 8C). Representative image of cells
infected with each mutant under arginine high and low conditions
are shown in Fig. 8D.
The above results argued that ROP16/STAT6-dependent
arginase-1 induction played a role on slowing parasite growth. To
test this, we compared growth of DROP16 and DROP16:1
parasites in peritoneal macrophages from Stat6
+/+ and Stat6
2/2
mice. Parasites expressing Type I ROP16 clearly displayed a
growth disadvantage in WT cells that was eliminated in Stat6
gene-deleted macrophages (Fig. 8E-G). As expected DROP16
parasites, which do not trigger STAT6 activation, replicated
equivalently in wild-type and knockout cells (Fig. 8E–G). Next,
we performed the same experiment employing macrophages from
Arg1
2/2 and Arg1
+/+ littermate control mice. As shown in
Fig. 8H-J, while DROP16:1 replicated less well than DROP16
parasites in wild-type MØ, the strains replicated equivalently in
Arg1
2/2 cells. We conclude that ROP16 mediates STAT6-
dependent arginase-1 induction, thereby modulating arginine
availability and resulting in parasite sensitivity to arginine
starvation conditions.
Influence of ROP16 on IL-12 production, parasite
replication, and dissemination during in vivo infection
To investigate the effect of ROP16 deletion during in vivo
infection, mice were i. p. inoculated with wild-type, or DROP16
parasites. Peritoneal exudate cells (PEC) were collected 2, 3 and 4
days post-infection and analyzed by Western blot for STAT3 and
STAT6 phosphorylation. In agreement with our in vitro results,
both of these signaling intermediates were phosphorylated in a
ROP16-dependent manner (Fig. 9A). In Fig. S5, we i. p. infected
mice with RH, DROP16 and DROP16:1 and collected PEC 5
days later. The results confirm that deletion and re-introduction of
ROP16 controls STAT3 and STAT6 activation in vivo. PEC
collected 24 hr post-infection were analyzed for ex vivo IL-12
production. As shown in Fig. 9B, cells from DROP16-infected
mice produced significantly higher levels of IL-12p40 relative to
cells from mice infected with wild-type parasites. Both wild-type
and DROP16-infected mice succumbed with the same kinetics
after i. p. infection, despite evidence for increased IL-12
production during DROP16 infection (Fig. S6).
We examined the course of acute infection in the peritoneal
cavity following parasite inoculation with 10
6 tachyzoites. At 6 hr
post infection (Fig. S7), similar levels of CD11b
+ cells were
observed in the RH and DROP16 infections, and the percent
infection was equivalent. Flow cytometric analysis revealed the
CD11b
+ cells to be inflammatory monocytes and approximately
10% neutrophils (data not shown). By 24 hr post-infection, the
percentage of infected cells was approximately 2-fold higher in
mice infected with DROP16 parasites. After 72 hr of infection,
Figure 7. DROP16 parasites are resistant to arginine deficient conditions. (A-D) Fibroblasts were cultured in complete (A, B) or arginine-
deficient (C, D) medium 24 hr prior to and during infection with RH (A, C) or DROP16 (B, D) tachyzoites. Cells were fixed and stained for intracellular
parasites (green) 48 hr after infection. Nuclear staining (DAPI) is shown in blue. (E) Number of tachyzoites per vacuole in infected fibroblasts under
normal and arginine-deficient conditions. (F) The experiments were repeated in bone marrow-derived MØ using RH, DROP16 and DROP16:1
tachyzoites at a 1:1 ratio of parasites to cells. * p,0.05. These experiments were repeated three times with similar result.
doi:10.1371/journal.ppat.1002236.g007
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cells were collected, cultured under Arg
high or Arg
low conditions and infected with the three parasite strains for 48 hr. In (A), the average number of
tachyzoites per cell was calculated for approximately 100 infected cells. In B and C, the number of cells harboring the indicated number of parasites is
shown, depicting the downshift in replication cycles for RH and the ROP16-complemented strains when arginine is limited (C). (D) Representative
images of infected peritoneal exudate cells for experiments in A-C. In panel E, the average number of tachyzoites per cell (n=100 infected cells) is
shown 48 hr after infection of resident macrophages from Stat6
+/+ and Stat6
2/2 mice. Number of cells containing the indicated number of parasites
is shown for Stat6
+/+ (F) and Stat6
2/2 (G) resident peritoneal MØ. Panel H, number of tachyzoites per cell (n=100) at 48 hr post-infection in Arg1
2/2
and Arg1
+/+ MØ. Panels I and J show number of parasites per cell in Arg1
+/+ and Arg1
2/2 MØ, respectively. *, p,0.05.
doi:10.1371/journal.ppat.1002236.g008
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compared to 54% with the wild-type parasite strain. We also
infected mice with a 10-fold lower dose of parasites and collected
PEC 72 hr later for parasite quantitation by qPCR. The results
(Fig. S7B) show increased numbers of parasites per host cell during
infection with DROP16 relative to WT parasites.
We performed similar experiments employing DROP16:1
tachyzoites in parallel with RH and DROP16 parasites. As shown
in Fig. 9C, while deletion of rop16 promoted parasite infection in
the peritoneal cavity, re-introduction of the gene into the deletion
mutant decreased tachyzoite-positive cells to levels similar to RH
infection. Increased parasite level resulting from ROP16 deletion
was also found in various tissues (liver, lung, spleen) harvested from
3-day infected mice. Levels of the parasite B1 gene were
significantly higher after infection with DROP16 parasites relative
to the parental RH strain in all tissues except for the brain
(Fig. 9D). In Fig. 10, we assessed downstream IFN-c production
and parasite numbers in spleen following infection. In the spleen
IFN-c levels displayed a ROP16-dependent increase (Fig. 10A).
There was a concomitant increase in parasites per host cell in the
spleen that depended upon the presence of Type I ROP16
(Fig. 10B).
Evidence that ROP16-dependent arginase-1 induction in
infected MØ limits in vivo parasite replication and
dissemination
We next examined whether ROP16 was involved in arginase-1
induction during in vivo infection. To test this, we infected mice by
Figure 9. Effects of ROP16 on cytokine production and parasite replication during in vivo infection. (A) C57BL/6 mice were infected by i.
p. injection with 10
6 tachyzoites of either RH or DROP16 strains. Peritoneal exudate cells were collected at 2, 3 and 4 days post-infection, lysed and
subjected to Western blot analysis using antibodies to total and phosphorylated STAT3 and STAT6. (B) Peritoneal exudate cells collected 24 hr post-
infection were cultured 24 hr without further stimulation and supernatants were assayed for IL-12p40 cytokine. Bars represent individual mice. (C)
Mice (n=4 per group) were infected with 10
5 RH, DROP16, DROP16:1 tachyzoites, then cells were collected 48 hr later and stained for surface CD11b
expression and intracellular tachyzoites using anti-SAG-1 antibody followed by flow cytometric analysis. The data show percent infected cells in
CD11b
+ and CD11b
2 populations. D, Mice were i.p. infected with 10
6 tachyzoites and organs were harvest 72 hr post infection. Tissues were
subjected to quantitative real time PCR amplification of the Toxoplasma B1 gene. Each symbol represents a single mouse. *p,0.01. This experiment
was performed twice with similar results.
doi:10.1371/journal.ppat.1002236.g009
Figure 10. DROP16 infection induces high-level IFN-c production in spleen. (A) Splenocytes were isolated from Day 7 mice infected with
each of the three strains (10
5 tachyzoites) and cultured without further stimulation for 72h. Supernatants were assayed for IFN-c. (B) Splenocytes were
also subjected to qPCR amplification of the Toxoplasma B1 gene and parasites were related to cell number by determining genome equivalents of
host argininosuccinate lyase. *, p,0.02.
doi:10.1371/journal.ppat.1002236.g010
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6 parasites of either strain and measured Arg-
1 expression levels by qPCR. Within 4 days of infection, we
detected strong Arg-1 up regulation during RH infection. Notably,
RH induced approximately two-fold more Arg-1 than DROP16
(Fig. 11A). Likewise, when mesenteric lymph node lysates were
subjected to Western blotting for arginase-1 (Fig. 11B), we found
that the protein was expressed at higher level during RH infection.
We tested the hypothesis that ROP16-mediated arginase-1
expression in infected cells limited the replication and dissemina-
tion of the parasite during in vivo infection. Straightforward
infection of arginase-1 knockout or MØ-specific arginase-1
knockout mice was problematic because of issues of lethality for
arginase-1 knockout mice. In addition, cytokines such as IL-4
produced during infection could mediate arginase-1 induction in
infected and noninfected cells, and this could also complicate the
results. Therefore, we adopted the approach outlined in Fig. 11C.
Wild-type and Arg1
2/2 CD45.1
+ MØ were infected with RH or
with DROP16 parasites. After removing extracellular tachyzoites,
infected MØ were transferred into the peritoneal cavities of wild-
type CD45.2
+ congenic mice. Two days after transfer, PEC were
collected and host cell infection levels were analyzed by flow
cytometry. We reasoned that if ROP16-mediated arginase-1
induction limited in vivo growth, emergence of DROP16 parasites
and subsequent infection of CD45.2 host cells would occur more
rapidly than during RH infection. The results are plotted as the
ratio of percent host infection in recipients of infected Arg1
2/2
MØ relative to recipients of Arg1
+/+ MØ. Indeed, there was large
increase in infection rate when wild-type parasites entered the host
in Arg1
2/2 MØ compared to Arg1
+/+ cells (Fig. 11D). In contrast,
the MØ genotype made no difference in dissemination to the host
during DROP16 infection.
Discussion
Toxoplasma displays an unusual population structure in that 3
clonal lineages predominate in Europe and North America [43].
Type I strains are highly virulent in mice, whereas strain types II
and III are less virulent and can establish latent infection.
Importantly, there is evidence that Type I strains also cause more
serious disease in humans [44]. Studies in mice suggest that the
immune response is an important determinant of virulence,
although its exact role is unclear. For example, infection with Type
I strains is associated with overproduction of proinflammatory
cytokines, whereas the response during Type II infection is more
restrained [45,46]. Paradoxically, Type II tachyzoites stimulate
higher levels of MØ IL-12 production compared to Type I
parasites during in vitro infection [27,28].
Toxoplasma strain type is an important determinant of activation
of STAT signaling pathways during intracellular infection.
Forward genetic analysis identified ROP16 as a polymorphic
parasite kinase controlling strain-specific activation of STAT3 and
STAT6, as well as modulating production of IL-12p40 [19]. Here,
we employed a reverse genetic approach to generate ROP16
deletion mutants as well as control complementation mutants to
gain insight into the biological role of this rhoptry molecule during
infection.
Previously, it was found that Type I strain parasites induces
rapid and sustained STAT3 activation associated with low-level
IL-12 production in mouse MØ [17,27,28]. In contrast, Type II
Toxoplasma fails to sustain STAT3 activation, and this was
genetically linked to high level IL-12 synthesis [19]. We found
Type I parasites lacking ROP16 were severely defective in STAT3
tyrosine phosphorylation. Nevertheless, DROP16 parasites main-
Figure 11. ROP16-dependent arginase-1 induction limits in vivo infection. (A) C57BL/6 mice (3 per group) were infected with the indicated
parasite strains and qPCR for the Arg-1 gene was performed on brain RNA at 4 days post-infection. Expression levels are shown relative to levels in
noninfected mice. (B) Mice were infected with RH or DROP16 tachyzoites then 4 days later mesenteric lymph node lysates were subjected to
immunoblot analysis using antibodies to arginase-1 and GAPDH. Each band represents the result from an individual animal. (C) Schematic for transfer
of infected Arg-1
+/+ or Arg-1
2/2 CD45.2
+ MØ into congenic CD45.1
+ host peritoneal cavities. (D) Relative infection level in host cells following transfer
of RH or DROP16-infected Arg-1
+/+ and Arg1
2/2 MØ. Infection in host CD45.2
+ cells was measured 48 hr following transfer of infected MØ. The data
are plotted as host infection in recipients of infected Arg1
2/2 relative to Arg1
+/+ MØ, and the numbers indicate percent infection 6 SD in each case.
These experiments were repeated 2–3 times with similar results.
doi:10.1371/journal.ppat.1002236.g011
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essentially identical to previous data from genetic crosses
indicating that Type I ROP16 is required for sustained STAT3
activation rather than the initial response [19]. Nevertheless,
recent in vitro kinase studies have shown that both STAT3 and
STAT6 serve as direct substrates for ROP16 tyrosine kinase
activity [21,22]. Therefore, we propose that there are two STAT3
activation phases. The first occurs rapidly and independently of
ROP16, and possibly involves activation of JAK molecules. The
second wave is necessary for sustained STAT3 activation in
Toxoplasma-infected cells and is likely dependent upon direct
tyrosine kinase activity of Type I ROP16. Interestingly, STAT6
tyrosine phosphorylation differed from STAT3 tyrosine phos-
phorylation insofar as deletion of ROP16 completely eliminated
the parasite’s ability to activate this signal transducing molecule.
Therefore, STAT6 activation during infection is entirely depen-
dent upon the parasite kinase.
Deletion of ROP16 converts Type I parasites from low to high
inducers of IL-12. Here, we show that this response, like that
induced by the Type II Toxoplasma ME49 strain, is highly
dependent upon the common adaptor MyD88. This molecule is
involved in signal transduction through most TLR, as well as
signaling through receptors for IL-1b and IL-18 [47]. We assessed
whether TLR2, 4, 9 and 11, MyD88-dependent TLR implicated
in the response to Toxoplasma [48], were responsible for high level
IL-12 production induced by the DROP16 strain. However, using
TLR knockout MØ, we found no evidence for involvement of
these TLR, and we formally ruled out autocrine IL-1b and IL-18
activity using MØ from caspase-1 knockout mice. The ROP16-
dependent and MyD88-dependent IL-12 production that we
observe may result from redundant functions of multiple TLR, or
it is possible that Toxoplasma itself may be capable of bypassing
TLR and use a novel mechanism to directly trigger MyD88-
dependent signaling.
Toxoplasma is known to inhibit signaling through TLR ligands
such as LPS, and we previously found that this activity was
dependent upon STAT3 [17]. Here, we show that ROP16
controls the ability to suppress TLR4-triggered IL-12p40 and
TNF-a production. We reported recently that T. gondii interferes
with LPS-induced chromatin remodeling at the TNF promoter by
blocking phosphorylation and acetylation of histone H3, suggest-
ing one mechanism for the suppressive effects of the parasite [49].
However, ROP16 does not appear to be involved in this activity,
because DROP16 parasites maintain the ability to inhibit TLR4-
mediated histone H3 modification (data not shown). The
biological significance of the down-regulatory effects of Toxoplasma
on TLR signaling is not yet clear. Since Toxoplasma infection is
naturally acquired via oral ingestion of parasites, one possibility is
that inhibition is a way to evade the activating effects of bacterial
TLR ligands that the host is exposed to during T. gondii infection in
the intestine [50,51]. Alternatively, it is possible that down-
regulating TLR signaling is a way for the parasite to avoid the
activating effects of its own TLR ligands.
Toxoplasma also interferes with signaling mediated by IFN-c
[37,52,53]. In order to assess this response, we first examined bone
marrow-derived and thioglycollate-elicited MØ NO production.
In our hands these cells produced undetectable amounts of NO in
response to IFN-c (data not shown). However, both astrocytes and
microglial cells are known to produce NO [54,55], and indeed we
found that IFN-c stimulation of these cells resulted in NO release.
While wild-type parasites were able to suppress the response, the
DROP16 strain was defective in inhibitory activity. Insight into
the functional significance of this response may come from the
observation that ability to express inducible NO, in particular by
microglial cells, is involved in controlling chronic infection in the
mouse brain, whereas animals survive acute infection without the
iNOS enzyme [56,57,58]. Therefore, expression of ROP16 may
be a parasite mechanism to increase transmission potential by
escaping the microbicidal effects of NO in the central nervous
system.
Despite the finding that absence of ROP16 results in enhanced
IL-12 production and defective ability to inhibit production
of proinflammatory mediators, replication and dissemination of
tachyzoites was enhanced by deletion of ROP16. We obtained
evidence that the reduced replication and dissemination of
parental RH parasites compared to DROP16 parasites was due
to arginine starvation resulting from ROP16-dependent
STAT6-mediated induction of arginase-1. The dependence of
Toxoplasma-induced arginase-1 expression on STAT6 activation we
observed is in contrast to previously published results by El Kasmi
et al. [40]. In that study, the authors observed STAT6 activation
by Type II ROP16, a result not seen by us or others [19,21].
Likewise, the authors reported STAT6-independent arginase-1
induction during infection with Type II ROP16-expressing
parasites, a result that also stands in contrast to our findings. At
present we do not understand the reason for these discrepant
results, but because El Kasmi et al. used ME49 without
manipulation of ROP16 a certain degree of caution regarding
STAT6-dependent arginase-1 induction may be warranted.
Regardless, our data are consistent with a view that ROP16-
mediated induction of arginase-1 functions to limit parasite
replication, and that this is a strategy to facilitate host survival
and establishment of latent infection to increase transmission
potential. An alternative view comes from the consideration that
arginase-1 and iNOS compete for the same substrate - namely,
arginine. Thus, ROP16-mediated arginase-1 induction, and
consequent arginine depletion in infected cells, may represent a
mechanism used by Type I strain parasites to evade the potentially
lethal effects of high-level NO production. Consistent with this
concept, we previously reported that Type II ME49 infection, in
contrast to Type I RH infection, resulted in NO production during
in vivo infection in the spleen even though overall cytokine
synthesis was greater during Type I infection [45,46].
More evidence for an in vivo role of arginase-1 during infection
comes from recent findings with Leishmania major and Schistosoma
mansoni [59,60]. In those studies, arginase-1 induction in myeloid
cells promoted infection by localized depletion of arginine, in turn
leading to suppressed T cell responses. This could possibly have
relevance to in vivo responses during Toxoplasma infection, insofar
as several older studies suggested that acute infection is associated
with nonspecific T cell suppression [61,62,63]. We are currently
re-examining this issue.
Our study demonstrates ROP16 manipulates host cell signaling
pathways that determine availability of arginine for parasite
replication and dissemination, and host production of NO. By
manipulating arginase-1 levels and consequently arginine avail-
ability to both host and parasite, ROP16 may act as a central
regulator of parasite replication and transmission potential. In
addition to ROP16-mediated control of host arginase-1, it seems
possible, and even likely, that ROP16 has additional functions
during intracellular infection. The ROP16 molecule is involved in
activation of STAT3 and STAT6, transcription factors that each
possess their own unique targets. Microarray analysis of host cell
responses also suggests that ROP16 has multiple downstream
targets [21]. Thus, ROP16 is emerging as a molecule at the
nexus of the host-parasite interaction, and as such may function as
one of the key determinants of strain-specific virulence and
transmissibility.
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Materials and Methods
Ethics statement
The experiments in this study were performed in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health. The protocols were approved by the Institutional Animal
Care and Use Committee at Cornell University (permit number
1995-0057). All efforts were made to minimize animal suffering
during the course of these studies.
Mice
Female C57BL/6 mice, 6–8 wks of age, were purchased from
Taconic Farms (Germantown, NY). STAT6
2/2 mice (provided by
M. Bynoe), TLR2
2/2/TLR4
2/2 mice (provided by D. Russell) and
MyD88
2/2 animals, originally supplied by S. Akira (Osaka
University), were bred in-house at Cornell University. Caspase-1
2/2
and JAK3
2/2 mice were obtained from The Jackson Laboratory
(Bar Harbor, ME). TLR9
2/2 mice were bred in house at
UT-Southwestern Medical School and Arg-1
2/2 mice were bred at
the University of Cincinnati College of Medicine. Animals were
housed under specific pathogen-free conditions in the Cornell
University College of Veterinary Medicine animal facility,
which is accredited by the Association for the Assessment and
Accreditation of Laboratory Animal Care International.
Parasites
Tachyzoites were maintained by twice weekly passage on
human foreskin fibroblast monolayers in DMEM (Life Technol-
ogies, Gaithersburg, MD) supplemented with 1% heat-inactivated
bovine growth serum (HyClone, Logan, UT), 100 U/ml penicillin
(Life Technologies), and 0.1 mg/ml streptomycin (Life Technol-
ogies). Parasite cultures were tested every 4–6 weeks for Mycoplasma
contamination using a commercial PCR-ELISA based kit (Roche
Applied Systems, Mannheim, Germany).
Antibody sources
Cell Signaling Technology (Danvers, MA) was the source of
antibodies to total and phospho-STAT3, JAK1, JAK2, ERK1/2
PARP and GAPDH. Anti-CD11b and anti-phospho-STAT6 were
purchased from BD Biosciences (San Jose, CA). FITC-conjugated
anti-p30 was purchased from Argene, Inc. Dr. Sidney Morris
(University of Pittsburgh) generously provided the arginase-1
antibody.
Gene knockout targeting plasmid constructs
The Type I ROP16 gene locus is defined by TGGT1_063760
in the current T. gondii genome database www.Toxodb.org (version
6.0). Gene knockout targeting plasmid pDROP16 was constructed
by fusing through yeast recombinational cloning [64] a ,1.2 kb 59
ROP16 target flank amplified from RH genomic DNA, the
HXGPRT minigene cassette [24] and a ,1.2 kb 39 ROP16 target
flank amplified from RH genomic DNA in correct order into the
yeast-shuttle plasmid pRS416. The deletion was engineered to
remove a small portion of the 59 UTR and essentially all of the
coding region with the exception of a few codons near the
predicted translation stop of ROP16, to create a ,2.2 kb deletion
in the DROP16 knockout strain. Complementation plasmid
pDROP16:1 was generated by fusing a c-terminal HA-tagged
functional allele of Type I RH ROP16 with 59 and 39 ROP16
target flanks. The oligonucleotide primers used in gene knockout
and complementation plasmid construction are shown in Table
S1. Targeting plasmids were validated by restriction digest, and by
DNA sequencing to verify 100% homology in gene targeting
flanks.
Gene replacement at the rop16 locus
Approximately 10 mg of PmeI linearized pDROP16 targeting
plasmid was individually transfected into T. gondii strain
RHDku80Dhxgprt that exhibits highly enhanced homologous
recombination and knockouts were then selected in mycophenolic
acid (MPA) using previously described methods [24]. Individual
MPA resistant clones were isolated and the genotype of the clones
was evaluated by PCR as previously described [24]. Genotype
validation primers are shown in Table S1. PCR 1 (rop16 deletion)
used primers DF and DR. PCR 2 used primers EXF & CXR. PCR
3( 5 9 integration) used primers CXF and pminiHXR. PCR 4
(39 integration) used primers CXR and pminiHXF [24]. The
DROP16:1 complemented strain was generated by retargeting
the ROP16-deleted locus with plasmid pDROP16:1 to delete
HXGPRT and reinsert a c-terminal HA-tagged functional allele of
Type I RH ROP16. Following transfection of the DROP16
knockout strain with 10 mg of PmeI linearized pDROP16:1
targeting plasmid, parasites were selected in 6-thioxanthine
(6TX) for removal of the HXGPRT selectable marker [24]. The
complemented DROP16:1 strain was validated in PCR by
showing correct 59 and 39 integration of the Type I ROP16 allele
at the ROP16 locus. PCR 5 (59 integration) used primers CXF and
cvR. PCR 6 (39 integration) used primers cvF and CXR.
Virulence assay
Adult 8-week-old female CF1 mice were obtained from Charles
River Laboratories and maintained in Techniplast Seal Safe
mouse cages on vent racks at the Dartmouth-Hitchcock Medical
Center (Lebanon, NH) mouse facility. All mice were cared for and
handled according to the Animal Care and Use Program of
Dartmouth College using National Institutes of Health-approved
institutional animal care and use committee guidelines. Groups of
four mice were injected intraperitoneally with 0.2 ml (100
tachyzoites) and monitored daily for degree of illness and survival.
Bone marrow-derived MØ and DC preparation
MØ were derived from bone marrow by 5-day culture in
L929-containing supernatants as previously described [65]. DC
were prepared as described previously [66].
Generation of astrocytes and microglia
Astrocytes and microglia were generated from the brains of 3-4
day old mice as previously described [67] with minor modifica-
tions. Briefly, brains were homogenized through 40-micron cell
strainers and single cell suspensions were subjected to discontin-
uous Percoll gradient centrifugation (70:30:0). Astrocytes were
collected from the 30:0 interface and microglial cells from the
70:30 interface. Both cell types were cultured in DMEM/F12
medium supplemented with 10% bovine growth serum up to three
weeks. Microglial cells were additionally supplemented with
130 ng/ml recombinant GM-CSF (PeproTech, Inc. Rocky Hill
NJ). Medium was replaced every 3 days.
Cell culture
Infection was accomplished by addition of tachyzoites to cell
cultures (3:1 ratio of parasites to MØ). Plates were briefly
centrifuged (3 min, 200 x g) to synchronize contact between
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(100 ng/ml; S. minnesota, ultrapure, List Biological Laboratories,
Campbell, CA) was added 60 min after infection, and at varying
times cells were collected for biochemical assays. For measurement
of cytokine release, cells were infected with various parasite ratios
with and without subsequent LPS stimulation. Supernatants were
collected at times indicated in text. Total cell lysates and nuclear
extracts were prepared for Western blot analysis with the Nuclear
Extract Kit (Active Motif, Carlsbad, CA). In some experiments,
JAK inhibitor I (EMD Biosciences, La Jolla, CA) and JAK2
inhibitor III (EMD Biosciences) were added to cells 60 min prior
to infection. Arginine-free medium (Sigma-Aldrich) was supple-
mented with dialyzed bovine growth serum, leucine, lysine and
glucose. In addition, arginine-high medium was supplemented to
84 mg/L L-arginine. Arginine-low medium was not supplemented
with the amino acid.
Immunoblot analysis
Cells (10
6/sample) were lysed in reducing SDS sample buffer,
and DNA was sheared by forcing samples three times through a
27-gauge needle. After boiling for 3 min, cellular lysates were
separated by 10% SDS-PAGE, and proteins subsequently
electrotransferred onto nitrocellulose membranes (Schleicher
& Schuell, Keene, NH). Membranes were blocked in 5% nonfat
dry milk containing 0.1% Tween 20 (Sigma-Aldrich) in Tris-
buffered saline, pH 7.6 (TBST), for 1 hr at room temperature,
followed by incubation with primary antibodies according to the
manufacturer’s protocol (Cell Signaling Technology). After
washing blots in TBST, antibody binding was detected with an
HRP-conjugated secondary antibody (Jackson ImmunoResearch
Laboratories, West Grove, PA) in TBST containing 5% nonfat dry
milk for 1 hr at room temperature. Tyrosine phosphorylated
STAT6 was detected using a mouse antibody from BD Biosciences
followed by anti-mouse biotin-conjugated antibody (Thermo
Scientific, Rockford IL) and an anti-biotin horseradish peroxi-
dase-conjugated antibody (Cell Signaling Technology). After
washing blots in TBST, bands were visualized using an ECL
system (Lumi-GLO; Cell Signaling Technology).
Pull-down assay
Tachyzoites were added to bone marrow-derived MØ
(5610
7)a tar a t i oo f8 :1 ,c e l l swere pelleted (2000 rpm,
3 min), and incubated for 20 min at 37uC. In some experiments,
recombinant IL-6 (eBioscience; San Diego, CA; 100 ng/ml) was
added. Cells were washed in PBS and resuspended in Cell Lysis
Buffer containing a cocktail of protease and phosphates
inhibitors (Cell Signaling Technology), and the suspension was
subjected to brief sonication. After centrifugation (14, 000 rpm,
10 min, 4uC), the resulting pellet was resuspended in 100 ml
anti-phosphotyrosine-agarose (Cell Signaling Technology) and
t h es l u r r yw a sr o t a t e do v e r n i g h ta t4 uC. The agarose beads were
subsequently washed in Cell Lysis Buffer, resuspended in SDS
sample reducing buffer and incubated at 100uCf o r3m i n .A f t e r
pelleting the beads, samples were subject to SDS-PAGE and
immunoblot analysis.
Immunofluorescence microscopy
Coverslips bearing infected MØ or fibroblast monolayers were
fixed with 4% formaldehyde in PBS, rinsed with PBS and
incubated (1 h, room temperature) with indicated primary
antibodies and/or FITC-conjugated anti-P30 antibody diluted in
PBS containing 1% BSA and 10% donkey serum. Coverslips were
washed 3 times with PBS and then incubated (1 h, room
temperature) with secondary antibody in the same diluent. After
washing 3 times with PBS, coverslips were mounted with Pro-
Long Gold antifade (Invitrogen, Carlsbad, CA). Actin staining was
accomplished with Alexa-fluor 594-conjugated phalloidin accord-
ing to manufacturer’s instructions (Invitrogen).
PCR detection of Toxoplasma gondii
DNA extraction from tissue samples was carried using DNeasy
Blood and Tissue Kit (Qiagen Inc. Valencia, CA) following the
manufacturer’s instructions. Real-time PCR was performed
targeting the highly conserved 35-fold-repetitive B1 gene in
T. gondii [68]. A 25 ml-reaction mixture was prepared using 2X
Power SYBR Green PCR Master Mix (Applied Biosystems,
Carlsbad, CA) with 0.3 mM forward primer 59-GGA-GGA-CTG-
GCA-ACC-TGG-TGT-CG-39 and reverse primer 59-TTG-
TTT-CAC-CCG-GAC-CGT-TTA-GCA-G-39 [69]. Reactions
were carried out in an Applied Biosystems 7500 Fast Real Time
PCR System with the following thermal cycling conditions: 50uC
for 2 min, 95uC for 10 min, followed by 40 cycles at 95uCf o r
15 sec and 60uC for 1 min. All PCR amplifications were
subjected to dissociation analysis to confirm the specificity of
the reaction. Quantification of parasites was accomplished by
using a standard curve constructed with a series of known
quantity of the T. gondii RH strain over a range of 6 logs
corresponding to 10
5 to 1 parasite per reaction. Uninfected
tissues were used as negative controls and distilled sterile water
used as zero template controls.
Parasites per cell were determined by qPCR for detection of the
parasite B1 gene and host argininosuccinate lyase (NM_133768), a
gene that is absent from the Toxoplasma genome. Aliquots of 10
6
cells were centrifuged to pellet cells and extracellular
parasites. DNA was extracted with the E.Z.N.A tissue DNA kit
(Omega Bio-Tek). Using the Syber Green PerfeCTa low ROX kit
(Quanta Biosciences) B1 primers (listed above) were used to
determine parasite number and argininosuccinate lyase forward
(59TCT-TCG-TTA-GCT-GGC-AAC-TCA-CCT-39) and reverse
(59ATG-ACC-CAG-CAG-CTA-AGC-AGA-TCA-39) primers were
used to determine mouse cell number in replicate samples.
Standard curves were constructed as described above for both
species.
Quantitative reverse transcriptase PCR of Arg-1 gene
Total RNA was prepared from brain tissue by Trizol
purification and 1 mg was converted to cDNA using a commer-
cially available method (Quanta Biosciences, Gaithersburg, MD).
Quantitative PCR was performed on the Arg1 gene and
normalized to the expression of the housekeeping gene GAPDH
utilizing the SYBR green method (Quanta biosciences, Gaithers-
burg, MD) and ABI 7500 fast machine (Life Technologies
Corporation, Carlsbad, CA). Expression relative to noninfected
control samples was calculated utilizing the DDCt method. The
primer sequences employed were: 59-AAG-AAT-GGA-AGA-
GTC-AGT-GTG-G-39 (Arg1 forward); 59-GGG-AGT-GTT-
GAT-GTC-AGT-GTG-39 (Arg1 reverse); 59-AAT-GGT-GAA-
GGT-CGG-TGT-G-39 (GAPDH forward); 59-GTG-GAG-TCA-
TAC-TGG-AAC-ATG-TAG-39 (GAPDH reverse).
Cytokine ELISA and NO assay
IL-12(p40) was measured by ELISA as described [15], and
TNF-a and IFN-c was measured using a commercial kit according
to the manufacturer’s instructions (eBiosciences). Production of
nitric oxide was detected by measurement of NO2/NO3 by the
Griess reaction as described [70].
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Student’s t-test was used to analyze statistical differences
between groups. Values for P,0.05 were considered significant.
All experiments were repeated a minimum of two times.
Supporting Information
Figure S1 Analysis of JAK involvement in parasite-
induced STAT3 activation. (A) Bone marrow-derived MØ
were infected with RH strain parasites and 20 min later lysates
were prepared and subjected to immunoprecipitation with
anti-phosphotyrosine antibody followed by Western blotting
employing antibodies specific for STAT3, JAK1 or JAK2. (B)
Bone marrow-derived MØ from wild-type, JAK3
+/+ or Tyk2
+/+
mice were infected with RH strain tachyzoites (3:1 ratio of
parasites to cells), then at the indicated time points (min) cell
lysates were prepared and subject to immunoblot analysis. (C)
Bone marrow-derived MØ were infected as in (B) in the
presence of JAK inhibitor I (80, 20, and 1 nM) or the
equivalent dilution of DMSO carrier. Cell lysates were
prepared for immunoblot analysis 30 min post infection. (D)
MØ were treated with JAK2 inhibitor III and infected with
parasites or treated with rIL-6 (100 ng/ml). Cell lysates were
prepared 30 min later and subjected to Western blotting with
antibodies specific for phosphorylated Tyr (Y) STAT3 or
Erk1/2. These experiments were performed 3 times with
similar results.
(TIF)
Figure S2 Targeted gene replacement at the ROP16
locus. (A) Strategy for disruption of the ROP16 gene by a
double-crossover homologous recombination event in the strain
RHDku80Dhxgprt by using a ,1.2 kb 59 target flank and a
,1.2 kb 39 target flank on plasmid pDROP16. The PCR
strategy for genotype verification is depicted using primer pairs
to assay for products from the PCR (not to scale). (B, C, D) A
panel of six MPA resistant clones (numbered 1 to 6) was
evaluated in PCR assays to validated patterns consistent with
ROP16 knockout. Lane M is the DNA size ladder and lane C is
the parental control strain with the ROP16 locus intact. (B) The
parental strain control was posit i v ef o rP C R1( 3 9 6b p ) ,t oa s s e s s
deletion of ROP16 coding region, and the PCR 2 (586 bp)
product. (C, D) The parental strain control was negative for
PCR 3 (1240 bp) and PCR 4 (1218 bp) product. Targeted
DROP16 knockouts are positive for the PCR 2, PCR 3
(59 integration) and PCR 4 (39 integration) products, and
negative for the PCR 1 (deletion) product. All six MPA-resistant
clones show a pattern consistent with a targeted deletion of a
,2.2 kb region of the ROP16 gene. (E) Strategy for comple-
mentation of the DROP16 knockout strain (RHDku80-
Drop16::HXGPRT) with a c-terminal HA-tagged copy the type
IR Hrop16 coding region by double-crossover homologous
recombination. The PCR strategy for genotype verification is
depicted using primer pairs to assay for products from the PCR
(not to scale). (F, G, H) A panel of six 6TX resistant clones
(numbered 1 to 6) was evaluated in PCR assay to validate
patterns consistent with ROP16 complementation. Lane M is
the DNA size ladder, lane C is the RHDku80Dhxgprt control
strain (ROP16 intact) and C* is the parental DROP16 knockout
control strain lacking ROP16. (F) The RHDku80Dhxgprt control
strain and all 6TX resistant clones were positive for PCR 1
(396 bp). (G)
(59 integration) The RHDku80Dhxgprt control strain and all 6TX
resistant clones were positive for PCR 5 (1719 bp).
The DROP16 knockout strain (lane C*) was negative. (H)
(39 integration) The RHDku80Dhxgprt control strain and all 6TX
resistant clones were positive for PCR 6 (1078 bp). The
DROP16 knockout strain (lane C*) was negative. All six 6TX-
resistant clones show a pattern consistent with insertion of a
single copy of the type I ROP16 coding region at the ROP16
locus.
(TIF)
Figure S3 Deletion of ROP16 does not alter serine
phosphorylation of STAT3. Bone marrow-derived MØ were
infected with RH or DROP16 tachyzoites (3: 1 ratio of parasites to
cells), then total lysates were prepared at the indicated times (hr).
Immunoblot analysis was carried out using antibody to
phospho-Tyr
705 and phospho-Ser
727 STAT3. The experiment
was repeated three times with similar results.
(TIF)
Figure S4 STAT6 activation is wholly dependent on
ROP16 but STAT3 activation is partially dependent on
ROP16. Bone marrow-derived MØ were infected with RH and
DROP16 tachyzoites (3: 1 ratio of parasites to cells), then nuclear
lysates were prepared at the indicated times (hr). Immunoblotting
was carried out using anti-phospho-STAT6, then the blot was
successively stripped and re-probed with antibody specific for total
STAT6, phospho-STAT3, total STAT and PARP.
(TIF)
Figure S5 In vivo activation of STAT3 and STAT6 during
intraperitoneal infection. Mice (C57BL/6 strain) were
inoculated with 10
6 RH, DROP16 and DROP16:1 tachyzoites
and peritoneal exudate cells were collected 5 days later. Total cell
lysates were immunoblotted with antibody to phospho-STAT3,
then blots were successively stripped and re-probed for total
STAT3, phospho-STAT-6 and total STAT6. Each lane represents
a single mouse.
(TIF)
Figure S6 Mice infected with RH and DROP16 tachy-
zoites display equivalent mortality. Mice (CF1 strain) were
infected with 100 tachyzoites of each strain by i. p. inoculation.
(TIF)
Figure S7 Increased infection in the peritoneal cavity by
DROP16 tachyzoites. A, Mice were infected with 10
6 RH or
DROP16 parasites, then peritoneal exudate cells were
collected at the indicated times post-inoculation. Cells were
stained with anti-CD11b and anti-Toxoplasma SAG-1 and
subsequently analyzed by flow cytometry. This experiment is
representative of three performed. B, Mice (n=5 per group)
were infected with 10
5 RH and DROP16 tachyzoites and cells
in the peritoneal cavity were collected 72 hr for qPCR analysis
of the Toxoplasma B1 gene relative to host arginosuccinate
lyase. The data are expressed as parasites per peritoneal
exudate cell. Each symbol represents an individual mouse. *,
p,0.01. The experiment was repeated twice with similar
results.
(TIF)
Table S1 Primers used in ROP16 knockout and com-
plementation construction and validation. Bold segments
correspond to T. gondii sequences in primers used for fusing gene
segments.
(DOC)
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